Unternehmens-Profil
Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells a broad portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. It serves healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical companies, and the general public worldwide. Key segments include BD Medical, offering peripheral IV and advanced catheters, vascular access technologies, infusion therapy systems, prefillable drug delivery, and sharps disposal; BD Life Sciences, providing specimen collection, blood culturing, molecular testing, flow cytometry, and diagnostic reagents; and BD Interventional, featuring hernia repair, surgical infection prevention, peripheral intervention, urology, and critical care products. Following its spinoff, revenue derives primarily from BD Medical Essentials, Interventional, Connected Care, and Biopharma segments, with significant international operations. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company plays a vital role in advancing medical discovery, diagnostics, and care delivery across the healthcare sector.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 153,26 USD· Stand 07.05.2026
News · Becton, Dickinson and Company
- Is the Options Market Predicting a Spike in Becton Dickinson Stock?
- BD Stock Up in Pre-Market Post Q2 Earnings & Revenue Beat, Margins Up
- Becton, Dickinson and Company (BDX) Q2 2026 Earnings Call Transcript
- Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q2 Earnings
- Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates